Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W L Pines

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Food and Drug Law Journal|February 5, 2002
A history and perspective on direct-to-consumer promotionW L Pines
The Annals of Pharmacotherapy|December 1, 2000
Direct-to-consumer advertisingW L Pines
Food and Drug Law Journal|January 1, 1997
Major issues in marketing regulationW L Pines
Clinical Therapeutics|January 23, 1999
Direct-to-consumer promotion: an industry perspectiveW L Pines
FDA Consumer|November 9, 1975
Polyvinyl chloride: why FDA actedW L Pines
Food and Drug Law Journal|January 1, 1997
New challenges for medical product promotion and its regulationW L Pines
CAL [Magazine] Certified Akers Laboratories|April 1, 1973
Hexachlorophene: why FDA concluded that hexachlorophene was too potent and too dangerous to be used as it once wasW L Pines
Pharmaceutical Research|November 27, 2013
Research and publicityW L Pines
FDA Consumer|May 12, 1978
New prescription for drug regulationW L Pines
Drug Intelligence & Clinical Pharmacy|September 1, 1983
New drugs and FDA publicityW L Pines
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Food and Drug Law Journal|February 5, 2002
A history and perspective on direct-to-consumer promotionW L Pines
The Annals of Pharmacotherapy|December 1, 2000
Direct-to-consumer advertisingW L Pines
Food and Drug Law Journal|January 1, 1997
Major issues in marketing regulationW L Pines
Clinical Therapeutics|January 23, 1999
Direct-to-consumer promotion: an industry perspectiveW L Pines
FDA Consumer|November 9, 1975
Polyvinyl chloride: why FDA actedW L Pines
Food and Drug Law Journal|January 1, 1997
New challenges for medical product promotion and its regulationW L Pines
CAL [Magazine] Certified Akers Laboratories|April 1, 1973
Hexachlorophene: why FDA concluded that hexachlorophene was too potent and too dangerous to be used as it once wasW L Pines
Pharmaceutical Research|November 27, 2013
Research and publicityW L Pines
FDA Consumer|May 12, 1978
New prescription for drug regulationW L Pines
Drug Intelligence & Clinical Pharmacy|September 1, 1983
New drugs and FDA publicityW L Pines
Pageof 2